The effects of the combined formulation Cytoflavin and its individual components (meglumine sodium succinate, nicotinamide, riboflavin, and inosine) on depressive behavioral disorders (DBD) were studied in mice with alloxan diabetes. Cytoflavin was found to be effective in correcting deficits in the activity of animals in the open field test and significantly reduced “despair behavior” in a 6-min tail suspension test; it also produced a transient hypoglycemic effect. The DBD-correcting activity of Cytoflavin was shown to be associated mainly with meglumine sodium succinate. The effect was significantly less linked with nicotinamide, which also produced the transient hypoglycemic action of Cytoflavin. Riboflavin made an even smaller contribution to the positive psychotropic action of Cytoflavin. The most problematic component of Cytoflavin was inosine, courses of which significantly increased lethality in mice with alloxan diabetes. However, this effect of inosine was only apparent when used alone, and disappeared completely when used in Cytoflavin.
Similar content being viewed by others
References
S. A. Rumyantseva, A. I. Fedin, S. B. Bolevich, et al., Zh. Nevrol. Psikhiat., 110(8), 16 – 21 (2010).
E. V. Silina and S. A. Rumyantseva, Vest. Intensiv. Ter., No. 2, 82 – 88 (2006).
S. V. Okovityi, D. S. Sukhanov, V. A. Zaplutanov, et al., Klin. Med., No. 9, 63 – 68 (2012).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Éksperim. Klin. Farmakol., 5, 17 – 25 (2011).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Byull. Éksperim. Biol. Med., No. 1, 63 – 70 (2013).
R. A. Kopaladze, Usp. Fiziol. Nauk., 29(4), 74 – 92 (1998).
I. A. Volchegorskii, I. I. Dolgushin, O. L. Kolesnikov, and V. E. Tseilikman, Experimental Modeling and Laboratory Evaluation of the Body’s Adaptive Reactions [in Russian], Chelyabinsk State Pedagogical University, Chelyabinsk (2000).
L. Steru, Psychopharmacology, 85, 367 – 370 (1985).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Probl. Éndokrinol., No. 4, 20 – 24 (2009).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Éksperim. Klin. Farmakol., 72(2), 11 – 15 (2009).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 48, No. 3, pp. 3 – 8, March, 2014.
Rights and permissions
About this article
Cite this article
Volchegorskii, I.A., Rassokhina, L.M. & Ermakova, S.G. Effects of Cytoflavin and its Components on Behavioral Disorders in Mice with Alloxan Diabetes. Pharm Chem J 48, 143–148 (2014). https://doi.org/10.1007/s11094-014-1066-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-014-1066-y